// App-Quantinova.ai

e22048 : Circulating tumor cells (CTC) as a biomarker of response in patients with extensive-stage small cell lung cancer (EX-SCLC).

Researchers

Presenter

  • Chao H. Huang

Principal Investigators

  • Apar Kishor Ganti

  • Prakash Neupane

  • Peter J. Van Veldhuizen

  • G. Sitta Sittampalam

  • Sarah Schmitt

  • Sanjit Nirmalanandhan

  • Stephen K. Williamson

  • Jo Wick

  • Janie Smart

  • Sarah Ellen Spencer

  • Andrew K. Godwin

Medical Centers

  • University of Kansas Medical Center, Kansas City, MO

  • University of Kansas, Westwood, KS

  • University of Kansas Medical Center, Westwood, KS

  • Kansas City VA Medical Center, Kansas City, MO

  • NCI, Rockville, MD

  • University of Kansas Institute for Advancing Medical Innovation, Kansas City, KS

  • VA Nebraska Western Iowa Health Care System, Omaha, NE

  • University of Kansas Cancer Center - Molecular Oncology, Kansas City, KS

  • University of Kansas Medical Center, Department of Biostatistics, Kansas City, KS

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Small cell lung cancer

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved